Stockreport

Cel-Sci: Fabulous Story Stock Works To Pass Muster With FDA [Seeking Alpha]

Cel-Sci Corporation  (CVM) 
NASDAQ:AMEX Investor Relations: cel-sci.com/investor_relations.html
PDF I am a long-term follower and chronicler of CEL-SCI ( NYSE: CVM ). My initial CEL-SCI article was 08/2019's CEL-SCI: A Risky Bet. My most recent was 07/2023's "Cel-Sci: [Read more]